Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active component of a drug, excipients are the inactive or inert substances present in a drug. Scope of the Report: This report focuses on the Active Pharmaceutical Ingredient in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Teva Novartis Pfizer Johnson & Johnson Mylan North China Pharmaceutical Group Dr. Reddy?s Laboratories Roche Aurobindo pharma Sun Pharmaceutical Industries Boehringer Ingelheim GmbH Bayer BASF DSM Zhejiang Medicine Biocon Johnson Matthey Hisun Pharmacy Cambrex Shandong Xinhua Pharmaceutical Lonza group Huahai Pharmaceutical Haerbin Pharmaceutical Group Cipla Tian Yao Lupin North East Pharmaceutical Albemarle Shandong Lukang Pharmaceutical Jiangsu Hengrui Medicine Bachem Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America, Middle East and Africa Market Segment by Type, covers Synthetic API Biotech API Other Market Segment by Applications, can be divided into Non-steroidal Anti-inflammatory Drugs (NSAIDs) Oncology Drugs Anti-diabetic Drugs Cardiovascular Drugs Central Nervous System Drugs (CNS Drugs) Musculoskeletal Drugs Other Drugs There are 13 Chapters to deeply display the global Active Pharmaceutical Ingredient market. Chapter 1, to describe Active Pharmaceutical Ingredient Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Active Pharmaceutical Ingredient, with sales, revenue, and price of Active Pharmaceutical Ingredient, in 2015 and 2016; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016; Chapter 4, to show the global market by regions, with sales, revenue and market share of Active Pharmaceutical Ingredient, for each region, from 2011 to 2016; Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions; Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016; Chapter 11, Active Pharmaceutical Ingredient market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021; Chapter 12 and 13, to describe Active Pharmaceutical Ingredient sales channel, distributors, traders, dealers, appendix and data source.
Table of Contents Global Active Pharmaceutical Ingredient Market by Manufacturers, Regions, Type and Application, Forecast to 2021 1 Market Overview 1.1 Active Pharmaceutical Ingredient Introduction 1.2 Market Analysis by Type 1.2.1 Synthetic API 1.2.2 Biotech API 1.2.3 Other 1.3 Market Analysis by Applications 1.3.1 Non-steroidal Anti-inflamm
